ICON'S Firecrest Training Recognized by TransCelerate - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
ICON'S Firecrest Training Recognized by TransCelerate

Source: Applied Clinical Trials

ICON announced that TransCelerate has certified that its Firecrest GCP training is mutually acceptable for its members. Under this TransCelerate initiative, investigators completing the training will avoid having to repeatedly complete pre-qualification GCP training for every trial. According to ICON, its Firecrest training has some features not available in other training programs, which include the ability for sponsors to assign training requirements per specific job role; track training compliance and notify users of overdue training or re-certification due dates; and enhanced reporting capabilities to analyze and report completion metrics at a region, site or role level.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here